Antifungal agent

This page covers all Antifungal agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Fungal cell membrane and mitochondrial enzymes (polyvalent cation-dependent).

Targets

Fungal cell membrane and mitochondrial enzymes (polyvalent cation-dependent)

Phase 3 pipeline (3)

• SYD-101 0.03% · Sydnexis, Inc. · Dermatology/Infectious Disease
  SYD-101 is a topical antifungal agent that disrupts fungal cell membrane integrity.
• Loprox Cream 0.77% · Padagis LLC · Dermatology
  Ciclopirox olamine disrupts fungal cell membrane and mitochondrial function by chelating polyvalent cations, leading to fungal cell death.
• K301 · Moberg Pharma AB · Dermatology
  K301 is a topical antimicrobial agent designed to treat fungal nail infections by inhibiting fungal growth and promoting nail healing.